Paradoxical suppression of cellular senescence by p53
Open accessThe DOI matches its Crossref record; 39 of the 39 references it cites were found in a registry or an index.
Abstract
The tumor suppressor p53 is a canonical inducer of cellular senescence (irreversible loss of proliferative potential and senescent morphology). p53 can also cause reversible arrest without senescent morphology, which has usually been interpreted as failure of p53 to induce senescence. Here we demonstrate that p53-induced quiescence actually results from suppression of senescence by p53. In previous studies, suppression of senescence by p53 was masked by p53-induced cell cycle arrest. Here, we separated these two activities by inducing senescence through overexpression of p21 and then testing the effect of p53 on senescence. We found that in p21-arrested cells, p53 converted senescence into quiescence. Suppression of senescence by p53 required its transactivation function. Like rapamycin, which is known to suppress senescence, p53 inhibited the mTOR pathway. We suggest that, while inducing cell cycle arrest, p53 may simultaneously suppress the senescence program, thus causing quiescence and that suppression of senescence and induction of cell cycle arrest are distinct functions of p53. Thus, in spite of its ability to induce cell cycle arrest, p53 can act as a suppressor of cellular senescence.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“p53 has been shown to both promote and inhibit cellular senescence [243], [244] partly through its up and down regulation of ROS, and its effects on mTOR.”
From Redox control of senescence and age-related disease. (2017) · cites this paper as [243]
Citations
Cites
Vogelstein, B., Lane, D., & Levine, A. J. (2000) · Nature · doi:10.1038/35042675 · Cited by 6,607
In Vivo Activation of the p53 Pathway by Small-Molecule Antagonists of MDM2
Vassilev, L. T., Vu, B. T., Graves, B., Carvajal, D., Podlaski, F., Filipovic, Z., Kong, N., Kammlott, U., Lukacs, C., Klein, C., et al. (2004) · Science · doi:10.1126/science.1092472 · Cited by 4,661 · cited 2×
“Nutlin-3-a and -b were obtained from Sigma-Aldrich and Roche (38). p53, p21, and p53-GFP expressing adenoviruses (Ad-p53, Ad-p21, and Ad-p53-GFP) were described previously (20, 39) and obtained from Wafik El-Deiry (University of Pennsylvania).”
MethodBlinded by the Light: The Growing Complexity of p53
Vousden, K. H., & Prives, C. (2009) · Cell · doi:10.1016/j.cell.2009.04.037 · Cited by 3,163
The first 30 years of p53: growing ever more complex.
Levine, A. J., & Oren, M. (2009) · Nature Reviews Cancer · doi:10.1038/nrc2723 · Cited by 1,967 · cited 1×
“Three (3) d wash, 3 days after drug removal; 9 d wash, 9 days after drug removal, cells were stained with crystal violet and photographed.”
Methodp53 Target Genes Sestrin1 and Sestrin2 Connect Genotoxic Stress and mTOR Signaling
Budanov, A. V., & Karin, M. (2008) · Cell · doi:10.1016/j.cell.2008.06.028 · Cited by 1,326
The coordinate regulation of the p53 and mTOR pathways in cells
Feng, Z., Zhang, H., Levine, A. J., & Jin, S. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0502857102 · Cited by 1,235
Regulation of PTEN Transcription by p53
Stambolic, V., MacPherson, D., Sas, D., Lin, Y., Snow, B., Jang, Y., Benchimol, S., & Mak, T. W. (2001) · Molecular Cell · doi:10.1016/s1097-2765(01)00323-9 · Cited by 912
Awakening guardian angels: drugging the p53 pathway
Brown, C. J., Lain, S., Verma, C. S., Fersht, A. R., & Lane, D. P. (2009) · Nature Reviews Cancer · doi:10.1038/nrc2763 · Cited by 881 · cited 1×
“Nutlin-3a is a highly specific activator of p53 and no offtarget effects of the compound have been reported (5).”
BackgroundSestrin as a feedback inhibitor of TOR that prevents age-related pathologies
Lee, J. H., Budanov, A. V., Park, E. J., Birse, R., Kim, T. E., Perkins, G. A., Ocorr, K., Ellisman, M. H., Bodmer, R., Bier, E., et al. (2010) · Science · doi:10.1126/science.1182228 · Cited by 570
(1999) · PubMed · Cited by 546
Methods to Detect Biomarkers of Cellular Senescence
Itahana, K., Campisi, J., & Dimri, G. P. (2007) · Methods in Molecular Biology · doi:10.1007/978-1-59745-361-5_3 · Cited by 514
Delayed ageing through damage protection by the Arf/p53 pathway
Matheu, A., Maraver, A., Klatt, P., Flores, I., Garcia-Cao, I., Borras, C., Flores, J. M., Viña, J., Blasco, M. A., & Serrano, M. (2007) · Nature · doi:10.1038/nature05949 · Cited by 466 · cited 1×
“This illuminates the significance of observations of declining p53 function with age (33, 34) and explains why mild activation of p53 may increase life span in mice (35).”
BackgroundRapamycin decelerates cellular senescence
Demidenko, Z. N., Zubova, S. G., Bukreeva, E. I., Pospelov, V. A., Pospelova, T. V., & Blagosklonny, M. V. (2009) · Cell Cycle · doi:10.4161/cc.8.12.8606 · Cited by 391
Self-citationChang, B.-D., Xuan, Y., Broude, E. V., Zhu, H., Schott, B., Fang, J., & Roninson, I. B. (1999) · Oncogene · doi:10.1038/sj.onc.1203078 · Cited by 386
Growth stimulation leads to cellular senescence when the cell cycle is blocked
Demidenko, Z. N., & Blagosklonny, M. V. (2008) · Cell Cycle · doi:10.4161/cc.7.21.6919 · Cited by 377
Self-citationCoordination and communication between the p53 and IGF-1–AKT–TOR signal transduction pathways
Levine, A. J., Feng, Z., Mak, T. W., You, H., & Jin, S. (2006) · Genes & Development · doi:10.1101/gad.1363206 · Cited by 321
Coppé, J.-P., Patil, C. K., Rodier, F., Sun, Y., Muñoz, D. P., Goldstein, J., Nelson, P. S., Desprez, P.-Y., & Campisi, J. (2008) · PLoS Biology · doi:10.1371/journal.pbio.0060301 · Cited by 302 · cited 1×
“Our finding that p53 suppresses senescence can explain prior observations showing that loss of p53 resulted in amplification of the senescence-associated secretory and proinflammatory phenotype (24, 31) and organismal proinflammatory state (usually associated with aging) in mice (24).”
BackgroundOncogenic ras and p53 Cooperate To Induce Cellular Senescence
Ferbeyre, G., de Stanchina, E., Lin, A. W., Querido, E., McCurrach, M. E., Hannon, G. J., & Lowe, S. W. (2002) · Molecular and Cellular Biology · doi:10.1128/mcb.22.10.3497-3508.2002 · Cited by 290
Feng, Z., Hu, W., Teresky, A. K., Hernando, E., Cordon-Cardo, C., & Levine, A. J. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0708043104 · Cited by 264
p53 is a suppressor of inflammatory response in mice
Komarova, E. A., Krivokrysenko, V., Wang, K., Neznanov, N., Chernov, M. V., Komarov, P. G., Brennan, M., Golovkina, T. V., Rokhlin, O., Kuprash, D. V., et al. (2005) · The FASEB Journal · doi:10.1096/fj.04-3213fje · Cited by 247
Self-citationMutations That Increase the Life Span of C. elegans Inhibit Tumor Growth
Pinkston, J. M., Garigan, D., Hansen, M., & Kenyon, C. (2006) · Science · doi:10.1126/science.1121908 · Cited by 242
Use of genetic suppressor elements to dissect distinct biological effects of separate p53 domains.
Ossovskaya, V. S., Mazo, I. A., Chernov, M. V., Chernova, O. B., Strezoska, Z., Kondratov, R., Stark, G. R., Chumakov, P. M., & Gudkov, A. V. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.19.10309 · Cited by 171
Self-citationChang, B.-D., Broude, E. V., Fang, J., Kalinichenko, T. V., Abdryashitov, R., Poole, J. C., & Roninson, I. B. (2000) · Oncogene · doi:10.1038/sj.onc.1203573 · Cited by 168
Efeyan, A., Ortega-Molina, A., Velasco-Miguel, S., Herranz, D., Vassilev, L. T., & Serrano, M. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-0200 · Cited by 140 · cited 2×
“In agreement with this hypothesis, it was shown that mTOR activators— oncogenic Ras and MEK—facilitate senescence in the presence of p53 (27, 30).”
BackgroundRegulation of Protein Synthesis by Ionizing Radiation
Braunstein, S., Badura, M. L., Xi, Q., Formenti, S. C., & Schneider, R. J. (2009) · Molecular and Cellular Biology · doi:10.1128/mcb.00711-09 · Cited by 135
Wang, W., Takimoto, R., Rastinejad, F., & El-Deiry, W. S. (2003) · Molecular and Cellular Biology · doi:10.1128/mcb.23.6.2171-2181.2003 · Cited by 126
The tumor suppressor p53: Cancer and aging
Feng, Z., Hu, W., Rajagopal, G., & Levine, A. J. (2008) · Cell Cycle · doi:10.4161/cc.7.7.5657 · Cited by 112
Demidenko, Z. N., Shtutman, M., & Blagosklonny, M. V. (2009) · Cell Cycle · doi:10.4161/cc.8.12.8809 · Cited by 95
Self-citationp21Waf1/Cip1/Sdi1 mediates retinoblastoma protein degradation
Broude, E. V., Swift, M. E., Vivo, C., Chang, B.-D., Davis, B. M., Kalurupalle, S., Blagosklonny, M. V., & Roninson, I. B. (2007) · Oncogene · doi:10.1038/sj.onc.1210516 · Cited by 94
Self-citationDrakos, E., Atsaves, V., Li, J.-D., Leventaki, V., Andreeff, M., Medeiros, L. J., & Rassidakis, G. Z. (2009) · Leukemia · doi:10.1038/leu.2008.348 · Cited by 86
Demidenko, Z. N., & Blagosklonny, M. V. (2009) · Aging · doi:10.18632/aging.100115 · Cited by 81
Self-citationHuang, B., Deo, D., Xia, M., & Vassilev, L. T. (2009) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-09-0144 · Cited by 72
Nutlin-3 inhibits the NFκB Pathway in a p53 Dependent Manner: Implications in Lung Cancer Therapy
Dey, A., Wong, E. T., Bist, P., Tergaonkar, V., & Lane, D. (2007) · Cell Cycle · doi:10.4161/cc.6.17.4643 · Cited by 70 · cited 1×
“Finally, p53 inhibits the NF-κB pathway (24, 25).”
Defects in p21WAF1/CIP1, Rb, and c-myc signaling in phorbol ester-resistant cancer cells.
Blagosklonny, M. V., Prabhu, N. S., & El‐Deiry, W. S. (1997) · PubMed · Cited by 66
Self-citationCellular quiescence caused by the Mdm2 inhibitor Nutlin-3A
Korotchkina, L. G., Demidenko, Z. N., Gudkov, A. V., & Blagosklonny, M. V. (2009) · Cell Cycle · doi:10.4161/cc.8.22.10121 · Cited by 53
Self-citationConstantinou, C., & Clemens, M. J. (2005) · Oncogene · doi:10.1038/sj.onc.1208648 · Cited by 46
Activation of p53 stimulates proteasome‐dependent truncation of eIF4E‐binding protein 1 (4E‐BP1)
Constantinou, C., Elia, A., & Clemens, M. J. (2008) · Biology of the Cell · doi:10.1042/bc20070121 · Cited by 33
Applications of green fluorescent protein as a marker of retroviral vectors
Kandel, E., Chang, B.-D., Schott, B., Shtil, A. A., Gudkov, A. V., & Roninson, I. B. (1997) · Somatic Cell and Molecular Genetics · doi:10.1007/bf02674280 · Cited by 31
Self-citationp53‐induced inhibition of protein synthesis is independent of apoptosis
Constantinou, C., Bushell, M., Jeffrey, I. W., Tilleray, V. J., West, M., Frost, V. J., Hensold, J. O., & Clemens, M. J. (2003) · European Journal of Biochemistry · doi:10.1046/j.1432-1033.2003.03687.x · Cited by 25
Cited by
Mechanisms of implantation: strategies for successful pregnancy
Cha, J., Sun, X., & Dey, S. K. (2012) · Nature Medicine · doi:10.1038/nm.3012 · Cited by 1,357
The Cell–Cycle Arrest and Apoptotic Functions of p53 in Tumor Initiation and Progression
Chen, J. (2016) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a026104 · Cited by 1,222
Senescence and aging: the critical roles of p53
Rufini, A., Tucci, P., Celardo, I., & Melino, G. (2013) · Oncogene · doi:10.1038/onc.2012.640 · Cited by 798
Steelman, L. S., Chappell, W. H., Abrams, S. L., Kempf, C. R., Long, J., Laidler, P., Mijatovic, S., Maksimovic-Ivanic, D., Stivala, F., Mazzarino, M. C., et al. (2011) · Aging · doi:10.18632/aging.100296 · Cited by 553
Chappell, W. H., Steelman, L. S., Long, J. M., Kempf, R. C., Abrams, S. L., Franklin, R. A., Bäsecke, J., Stivala, F., Donia, M., Fagone, P., et al. (2011) · Oncotarget · doi:10.18632/oncotarget.240 · Cited by 510
Metadata
- Authors
- Demidenko, Z. N., Korotchkina, L. G., Gudkov, A. V., & Blagosklonny, M. V.
- Affiliations
- Roswell Park Comprehensive Cancer Center (US)
- ORCID
- Gudkov, Andrei V.
- Venue
- Proceedings of the National Academy of Sciences
- Publisher
- National Academy of Sciences
- Published
- 2010-05-10
- Volume
- 107
- Issue
- 21
- Pages
- 9660-9664
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- PMC
- PMC2906905
- OpenAlex
- W1979262539
- Cited by
- 273
- References
- 39
- Citations by year
- 2026: 5 · 2025: 10 · 2024: 5 · 2023: 7 · 2022: 11 · 2021: 7 · 2020: 6 · 2019: 7 · 2018: 10 · 2017: 8 · 2016: 15 · 2015: 16 · 2014: 32 · 2013: 35 · 2012: 38
- FWCI
- 29.03
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Proceedings of the National Academy of Sciences (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Cancer Institute (CA75179, CA 060730, R01CA060730, R01CA075179)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Telomeres, Telomerase, and Senescence
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Aging › Genetics, Aging, and Longevity in Model Organisms
- Keywords
- p53, cellular senescence, quiescence, p21, mTOR signaling, rapamycin, tumor suppressor
- MeSH terms
- Humans, Imidazoles, Piperazines, Signal Transduction, Transcriptional Activation, Tumor Suppressor Protein p53, Cellular Senescence, Protein Serine-Threonine Kinases, Cell Line, Tumor, Intracellular Signaling Peptides and Proteins, TOR Serine-Threonine Kinases
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.